The effects of randomized controlled trials on vertebroplasty and kyphoplasty: A square peg in a round hole

Pain Physician

Volumn 16, Issue 4, 2013, Pages

  Albers, Sheri L ^a   Latchaw, Richard E ^b  

^a Radiology Research and Consultation   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; LIDOCAINE; POLY(METHYL METHACRYLATE);

ANALGESIA; CONSERVATIVE TREATMENT; DIAGNOSTIC IMAGING; EDITORIAL; EVIDENCE BASED MEDICINE; GOVERNMENT; HUMAN; KYPHOPLASTY; MEDICAL DEVICE; MEDICAL ETHICS; MEDICAL PROCEDURES; PAIN; PERCUTANEOUS VERTEBROPLASTY; PHYSICAL EXAMINATION; PLACEBO EFFECT; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REIMBURSEMENT; SHAM PROCEDURE; SPINE FRACTURE; SPINE METASTASIS; WORKMAN COMPENSATION;

FRACTURES, COMPRESSION; HUMANS; KYPHOPLASTY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; VERTEBROPLASTY;

EID: 84880580506     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (192)

1. Galibert P, Deramond H, Rosat P, Le Gars D. Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty. Neurochirurgie 1987; 33:166-168.
2. Kallmes DF, Jensen ME. Percutaneous vertebroplasty 1. Radiology 2003; 229:27-36.
3. Do HM, Kim BS, Marcellus ML, Curtis L, Marks MP. Prospective analysis of clinical outcomes after percutaneous vertebroplasty for painful osteoporotic vertebral body fractures. AJNR Am J Neuroradiol 2005; 26:1623-1628.
4. Diamond TH, Bryant C, Browne L, Clark WA. Clinical outcomes after acute osteoporotic vertebral fractures: A 2-year non-randomised trial comparing percutaneous vertebroplasty with conservative therapy. Med J Aust 2006; 184:113-117.
5. Gill JB, Kuper M, Chin PC, Zhang Y, Schutt R Jr. Comparing pain reduction following kyphoplasty and vertebroplasty for osteoporotic vertebral compression fractures. Pain Physician 2007; 10:583-590.
6. Syed MI, Shaikh A. Vertebroplasty: A systematic approach. Pain Physician 2007; 10:367-380.
7. Afzal S, Dhar S, Vasavada NB, Akbar S. Percutaneous vertebroplasty for osteoporotic fractures. Pain Physician 2007; 10:559-563.
8. Afzal S, Dhar S, Vasavada NB, Akbar S. Percutaneous Vertebroplasty for Osteoporotic Fractures. Pain Physician 2007; 10:559-563
9. Ma XL, Xing D, Ma JX, Xu WG, Wang J, Chen Y. Balloon kyphoplasty versus percutaneous vertebroplasty in treating osteoporotic vertebral fractures: A randomized controlled trial. BMC Musculoskelet Disord 2008; 9:156.
10. Lee MJ, Dumonski M, Cahill P, Stanley T, Park D, Singh K. Percutaneous treatment of vertebral compression fractures: A meta-analysis of complications. Spine 2009; 34:1228-1232.
11. Klazen CA, Lohle PN, deVries J, Jansen FH, Tielbeek AV, Blonk MC, Venmans A, van Rooij WJ, Schoemaker MC, Juttmann JR, Lo TH, Verhaar HJ, van der Graaf Y, van Everdingen KJ, Muller AF, Elgersma OE, Halkema DR, Fransen H, Janssens X, Buskens E, Mali WP. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (VERTOS II): An open-label randomized trial. Lancet 2010; 276:1085-1092.
12. Boonen S, Van Meirhaeghe J, Bastian L, Cummings SR, Ranstam J, Tillman JB, Eastell R, Talmadge K, Wardlaw D. Balloon kyphoplasty for the treatment of acute vertebral compression fractures: 2 year results from a randomized trial. J Bone Miner Res 2011; 26:1627-1637.
13. Brodano GB, Amendola L, Martikos K, Bettuzzi C, Boriani L, Gasbarrini A, Bandiera S, Terzi S, Greggi T, Boriani S. Vertebroplasty: Benefits are more than risks in selected and evidence-based informed patients. A retrospective study of 59 cases. Eur Spine J 2011; 20:1265-1271.
14. Goz V, Koehler SM, Egorova NN, Moskowitz AJ, Guillerme SA, Hecht AC, Qureshi SA. Kyphoplasty and vertebroplasty: Trends in use in ambulatory and inpatient settings. Spine J 2011; 11:737-744.
15. Han S, Wan S, Ning L, Tong Y, Zhang J, Fan S. Percutaneous vertebroplasty versus balloon kyphoplasty for treatment of osteoporotic vertebral compression fracture: A meta-analysis of randomized and non-randomised controlled trials. Int Orthop 2011; 35:1349-1358.
16. Blasco J, Martinez-Ferrer A, Macho J, San Roman Manzanera L, Pomés Talló J, Carrasco Jordan JL, Monegal Brancós A, Guañabens Gay N, Peris Bernal P. Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: A 12-month randomized follow-up, controlled trial. J Bone Miner Res 2012; 27:1159-1166.
17. Anselmetti GC, Marica S, Saba L, Muto M, Bonaldi G, Carpeggiani P, Marini S, Manca A, Masala S. Percutaneous vertebroplasty: Multi-centric results from EVEREST experience in large cohort of patients. Eur J Radiol 2012; 81:4083-4086.
18. Anderson PA, royshteter AB, Tontz WL. Meta-analysis of vertebral augmentation compared with conservative treatment for osteoporotic spinal fractures. J of Bone Miner Res 2013; 28:372-382.
19. Buchbinder R, Osborne R, Ebeling PR, Wark JD, Mitchell P, Wriedt C, Graves S, Staples MP, Murphy B. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med 2009; 361:557-568.
20. Kallmes DF, Comstock BA, Heagerty PJ, Turner JA, Wilson DJ, Diamond TH, Edwards R, Gray LA, Stout L, Owen S, Hollingworth W, Ghdoke B, Annesley-Williams DJ, Ralston SH, Jarvik JG. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 2009; 361:569-579.
21. Lambert RGW, Golmohammadi K, Majumdar SR, Jones A, Buchbinder R, Dhillon SS, Owen R, Homik J, Kallmes DF, Siminoski KG. Percutaneous vertebroplasty for osteoporotic vertebral compression fractures. (Protocol) Cochrane Database of Systematic Reviews 2007; 1:CD006349.
22. Rousing R, Andersen MO, Jespersen SM, Thomsen K, Lauritsen J. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: Three-months follow-up in a clinical randomized study. Spine 2009; 34:1349-1354.
23. Staples MP, Kallmes DF, Comstock BA, Jarvik JG, Osborne RH, Heagerty PJ, Buchbinder R. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: Meta-analyses. BMJ 2011; 343:d3952.
24. Kallmes DF, Comstock BA. Commentary; No comparison conservative management of painful spontaneous osteoporotic compression fractures is the way to go. Spine J 2012; 12:1006-1007.
25. Glaros S. All evidence is not created equal: A discussion of levels of evidence. Phys Ther 2003; 11:42-47.
26. OCEBM Levels of Evidence Working Group. The Oxford 2011 levels of evidence. Oxford Centre for Evidence-Based Medicine. http://www.cebm.net/index.aspx?o=5653
27. U.S. Preventive Services Task Force (USPSTF). Grade definitions after July 2012. http://uspreventiveservicestask-force.org/ U.S. Preventive Services Task Force > Methods and Processes > Grade Definitions
28. Stanley K. Design of randomized controlled trials. Circulation 2007; 115:1164-1169.
29. Kallmes DF, Buchbinder R, Miller FG. Randomised controlled trials using invasive control interventions should be included in Cochrane Reviews [editorial]. The Cochrane Library 2011; 13:12.
30. Miller FG. The randomized controlled trial as a demonstration project: An ethical perspective. Am J Psychiatry 2009; 166:743-745.
31. Miller FG. The rationale for placebocontrolled trials: Methodology and policy considerations. Am J Bioeth 2009; 9:49-50.
32. Lilford RJ, Jackson J. Equipoise and the ethics of randomization. J R Soc Med 1995; 88:552-559.
33. Freedman, B. Equipoise and the ethics of clinical research. N Engl J Med 1987; 317:141-145.
34. Miller FG, Brody H. What makes placebo-controlled trials unethical? Am J Bioeth 2002; 2:1-7.
35. De Craen AJM, Kaptchuk TJ, Tijssen JGP, Kleijnen J. Placebos and placebo effects in medicine: Historical overview. J R Soc Med 1999; 92:511-515.
36. Kaptchuk TJ, Shaw JK, Conboy LA, Kelley JM, Csordas TJ, Lembo AJ, Jacobson EE. "Maybe I Made Up the Whole Thing." Placebos and patients; experiences in a randomized controlled trial. Cult Med Psychiatry 2009; 33:382-411.
37. Lenrow DA, Chou LH. Randomized controlled trials in interventional spine: Perils and pitfalls. Pain Physician 2003; 6:83-87.
38. Miller FG, Kaptchuk TJ. Sham procedures and the ethics of clinical trials. J R Soc Med 2004; 97:576-578.
39. Campbell AJ, Bagley A, Heest AV, James M. Challenges of radomized controlled surgical trials. Orthop Clin N Am 2010; 41:145-155.
40. Lotz JC. Trials of vertebroplasty for vertebral fractures. N Engl J Med 2009; 361: 2097-2100.
41. Emanuel EJ, Miller FG. The ethics of placebo-controlled trials-a middle ground. N Engl J of Med 2001; 345:915-919.
42. Finnis DG, Kaptchuk TJ, Miller FG, Benedetti F. Placebo effects: Biological, clinical and ethical advances. Lancet 2010; 375:686-695.
43. Horng S, Miller FG. Is placebo surgery unethical? N Engl J Med 2002; 347:137-139.
44. Brody H, Miller FG. The internal morality of medicine: Explication and application to managed care. J Med Philos 1998; 23:384-410.
45. Miller FG. Striking the right balance in research ethics and regulation. Am J Bioeth 2010; 10:65.
46. Miller FG. The Ethical Challenges of Human Research: Selected Essays. Oxford University Press, New York, 2012.
47. Smith GCS, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: Systematic review of randomised controlled trials. BMJ 2003; 327:20-27.
48. Horwitz RI. Complexity and contradiction in clinical trial research. Am J Med 1987; 82:498-510.
49. Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998; 29:4-11.
50. Bellomo R, Bagshaw S. Review evidence-based medicine: Classifying the evidence from clinical trials the need to consider other dimensions. Care 2006; 232:1-8.
51. Baerlocher MO, Peter L, Munk PL, Liu DM. Clinical utility of vertebroplasty: Need for better evidence. Radiology 2010; 255:669-674.
52. Dickinson K, Bunn F, Wentz R, Edwards P, Roberts I. Size and quality of randomised controlled trials in head injury: Review of published studies. BMJ 2000; 320:1308-11.
53. Prentice R. Ethics and sample size another view. Am J Epidemiol 2005; 161:111-112.
54. Halpern SD. Adding nails to the coffin of underpowered trials. J Rheumatol 2005: 32;2065-2066.
55. Keen HI, Pile K, Hill CL. The prevalence of under-powered randomized clinical trials in rheumatology. J Rheumatol 2005; 32:2083-2088.
56. Vickers AJ. Underpowering in randomized trials reporting a sample size calculation. J Clin Epidemiol 2003; 56:717-20.
57. Freiman JA, Chalmers TC, Smith H Jr, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized controlled trial: Survey of 71"negative" trials. N Engl J Med 1978; 299:690-694.
58. Chung KC, Kaliainen LK, Spilson SV, Walters MR, Kim HM. The prevalence of negative studies with inadequate statistical power: Analysis of the plastic surgery literature. Plast Reconstr Surg 2002; 109:1-6.
59. Bedard PL, Krzyzanowska MP, Tannock IR. Statistical power of negative randomized controlled trials. J Clinical Oncology 2007; 25:3482-3487.
60. Breau RH, Carnat TA, Gaboury I. Inadequate statistical power of negative clinical trials in urological literature. J Urol 2006; 176:263-266.
61. Demange MK, Fregni F. Limits to clinical trials in surgical areas. Clinics (San Paulo) 2011; 66:159-161.
62. Dimick JB, Diener-West M, Lipsett PA. Negative results of randomized clinical trials published in the surgical literature: Equivalency or error? Arch Surg 2001; 136:796-800.
63. Hebert R, Wright S, Dittus R, Elasy T. Prominent medical journals often provide insufficient information to assess the validity of studies with negative results. J Negat Results Biomed 2002; 1:1.
64. Halpern SD, Karlawish JHT, Berlin JA. The continuing unethical conduct of underpowered clinical trials. JAMA 2002; 288:358-62.
65. TEC Evaluation Center. Percutaneous vertebroplasty or kyphoplasty for vertebral fractures caused by osteoporosis. TEC Evaluation Program 2011; 25:1-54.
66. Eeric Truumees E, Frey ME, Moshirfar A, Miller S, Mroz TE, Vives MJ, Zaman FM. Vertebral body augmentation: Time for reassessment? Current Concepts 2010; May-June:13-20.
67. Clark W, Lyon S, Burnes J. Trials of vertebroplasty for vertebral fractures. N Engl J Med 2009; 361:2097-2100.
68. Baerlocher MO, Munk PL, Liu DM. Commentary on: Trials of vertebroplasty for vertebral fractures. N Engl J Med 2009; 361:2097-2100.
69. Clark WA, Burnes JP, Lyon SM. Vertebroplasty for acute osteoporotic fracturesposition statement from the Interventional Radiology Society of Australasia. J Med Imaging Radiat Oncol 2011; 55:1-3.
70. Bono CM, Heggeness M, Mick C, Watters WC 3rd; North American Spine Society. Newly released vertebroplasty randomized placebo-controlled trials: A tale of two trials. Spine J 2010; 10:238-240.
71. Wardlaw D, Cummings SR, Van Meirhaeghe J, Bastian L, Tillman JB, Ranstam J, Eastell R, Shabe P, Talmadge K, Boonen S. Efficacy and safety of balloon kyphoplasty compared with onsurgical care for vertebral compression fracture (FREE): A randomized controlled trial. Lancet 2009; 373:1016-1024.
72. Sackett DL, Rosenberg WMC, Muir Gray JA. Evidence-based medicine: What it is and what it isn't. BMJ 1996; 312:71-79.
73. Bono CM, Ghiselli G, Gilbert TJ, Kreiner DS, Reitman C, Summers JT, Baisden JL, Easa J, Fernand R, Lamer T, Matz PG, Mazanec DJ, Resnick DK, Shaffer WO, Sharma AK, Timmons RB, Toton JF. An evidence-based clinical guideline for the diagnosis and treatment of cervical radiculopathy from degenerative disorders. Spine J 2011; 11:64-72.
74. Brody H, Miller FG, Bogdan-Lovis E. Evidence-based medicine: Watching out for its friends. Perspect Biol Med 2005; 48:570-584.
75. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med 2009; 151:264-269.
76. Kallmes DF, Jarvik JG, Osborne RH, et al. Clinical utility of vertebroplasty: Elevating the evidence 1. Radiology 2010; 255:675-680.
77. Manchikanti L, Singh V, Caraway DL, Benyamin RM, Hirsch JA. Medicare physician payment systems: Impact of 2011 schedule on interventional pain management. Pain Physician 2011; 14:E5-33.
78. Manchikanti L, Falco FJE, Boswell MV, et al. Facts fallacies, and politics of comparative effectiveness research: Part 1. Basic considerations. Pain Physician 2010; 13:E23-54.
79. Manchikanti L, Falco FJE, Boswell MV, Hirsch JA. Facts, fallacies, and politics of comparative effectiveness research: Part 2. Implications for interventional pain management. Pain Physician 2010; 13:E55-79.
80. Agency for Health Care Research and Quality. What is Comparative Effectiveness Research? www.ahrq.gov.
81. Agency for Health Care Research and Quality. What is the Effective Health Care Program? www.ahrq.gov.
82. US Department of Health and Human Services. Agency for Health Care Research and Quality. www.ahrq.gov.
83. Agency for Health Care Research and Quality. Who is involved in the Effective Health Care Program>Research>Evidence-based Practice Centers. www.ahrq.gov.
84. Chou R, Loeser JD, Owens MD, Rosenquist RW, Atlas SJ, Baisden J, Carragee EJ, Grabois M, Murphy DR, Resnick DK, Stanos SP, Shaffer WO, Wall EM. Interventional therapies, surgery and interdisciplinary rehabilitation for low back pain. Spine 34; 10:1066-1077.
85. Manchikanti L, Datta S, Derby R, Wolfer LR, Benyamin RM, Hirsch JA. A critical review of the American Pain Society clinical practice guidelines for interventional Techniques: Part I. Diagnostic interventions. Pain Physician 2010; 13:E141-E174.
86. Manchikanti L, Datta S, Gupta S, Munglani R, Bryce DA, Ward SP, Benyamin RM, Sharma ML, Helm S 2nd, Fellows B, Hirsch JA. A critical review of the American Pain Society clinical practice guidelines for interventional techniques: Part 2. Therapeutic interventions. Pain Physician 2010; 13:E215-E264.
87. Manchikanti L, Benyamin RM, Falco FJE, Caraway DL, Datta S, Hirsch JA. Guideline warfare over interventional techniques: Is there a lack of discourse or straw man? Pain Physician 2012; 15:E1-26.
88. Centers for Medicare and Medicaid Services. CMS>home>Medicare>Accountable Care Organizations. www.CMS.gov.
89. US Department of Health and Human Services. About HHS>HHS Operating Divisions. www.HHS.gov.
90. Centers for Medicare and Medicaid Services. CMS>Innovations Center>Our Innovative Models>Health Care Innovation Awards.www.CMS.gov
91. Administration Implements New Health Reform Provision to Improve Care Quality, Lower Costs. (Newsroom>Fact Sheets) www.HealthCare.gov
92. Dougherty A. Getting serious about cost containment: Understanding the ACA's Independent Payment Advisory Board (IPAB). Sierra Sacramento Valley Medicine 2013; May/June:6-7.
93. California Anthem Blue Cross Provider Bulletin April 23, 2013.
94. Manchikanti L, Abdi S, Atluri S, Benyamin RM, Boswell MV, Buenaventura RM, Bryce DA, Burks PA, Caraway DL, Calodney AK, Cash KA, Christo PJ, Cohen SP, Colson J, Conn A, Cordner H, Coubarous S, Datta S, Deer TR, Diwan S, Falco FJ, Fellows B, Geffert S, Grider JS, Gupta S, Hameed H, Hameed M, Hansen H, Helm Ii S, Janata JW, Justiz R, Kaye AD, Lee M, Manchikanti KN, McManus CD, Onyewu O, Parr AT, Patel VB, Racz GB, Sehgal N, Sharma ML, Simopoulos TT, Singh V, Smith HS, Snook LT, Swicegood JR, Vallejo R, Ward SP, Wargo BW, Zhu J, Hirsch JA. Guidelines for interventional techniques Part II: Guidance and recommendations. Pain Physician 2013; 16:S49-S283.
95. Broderick JP. Interventional management of stroke-III investigators. N Engl J Med 2013: 368:893-903.
96. Pearson SD, Miller FG, Emanuel EJ. Medicare's requirement for research participation as a condition for coverage: Is it ethical? JAMA 2006; 296:988-991.
97. Gellijns AC, Ascheim DD, Parides MK, Kent KC, Moskowitz AJ. Randomized trials in surgery. Surgery 2009; 145:581-587.
98. McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D. Randomised trials in surgery: Problems and possible solutions. BMJ 2002; 324:1448-1451.
99. Hassanein AH, Herrera FA, Hassanein O. Challenges of randomized controlled trial design in plastic surgery. Can J Plast Surg 2011; 19:e28-e29.
100. Morrison WB, Parker L, Frangos A, Carrino JA. Vertebroplasty in the United States: Guidance method and provider distribution, 2001-2003. Radiology 2007; 243:166-170.
101. Brett AS. Use of vertebroplasty and kyphoplasty declined in 2010. J Watch General 2013; 201:237.
102. Long SS, Morrison WB, Parker L. Vertebroplasty and kyphoplasty in the United States: Provider and Guidance Method, 2001-2010. AJR 2012; 199:1358-1364.
103. Leake CB, Brinjikji W, Cloft HJ, Kallmes DF. Trends of inpatient spine augmentation: 2001-2008. AJNR Am J Neuroradiol 2011; 32:1464-1468.
104. Manchikanti L, Pampati V, Hirsch J. Analysis of utilization patterns of vertebroplasty and kyphoplasty in the Medicare population. J Neurointerv Surg 2012; July 7 [Epub ahead of print].
105. Lindsey SS, Kallmes DF, Optowsky MJ, Broyles EA, Layton KF. Impact of shamcontrolled vertebroplasty trials on referral patterns at two academic medical centers. Proc (Bayl Univ Med Cent) 2013; 26:103-105.
106. Manchikanti L, Singh V, Boswell MV. Interventional pain management at crossroads: The perfect storm brewing for a new decade of challenges. Pain Physician 2010; 13:E111-140.
107. Benyamin RM, Datta S, Falco FJE. A perfect storm in interventional pain management: Regulated, but unbalanced. Pain Physician 2010; 13:109-116.
108. Wulff KC, Miller FG, Pearson SD. Can coverage be rescinded when negative trial results threaten a popular procedure? The ongoing saga of vertebroplasty. Health Affairs 2011; 30:2269-2276.
109. Trout AT, Kallmes DF. Does vertebro-plasty cause incident vertbral fractures? A review of available data. AJNR Am J Neuroradiol 2006; 27:1397-1403.
110. Yen CG, Teng MMH, Yuan WH, Sun YC, Chang CY. Preventive vertebroplasty for adjacent vertebral bodies: A good solution to reduce adjacent vertebral fracture after percutaneous vertebroplasty. AJNR Am J Neuroradiol 2012; 33:826-832.
111. Georgy BA. Interventional techniques in managing persistent pain after vertebral augmentation procedures: A retrospective evaluation. Pain Physician 2007; 10:674-676.
112. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996; 312:1215-1218.
113. Bellomo R, Bagshaw S. Review evidence-based medicine: Classifying the evidence from clinical trials the need to consider other dimensions. Care 2006; 232:1-8.
114. Horwitz RI, Viscoli CM, Clemens JD, Sadock RT. Developing improved observational methods for evaluating therapeutic effectiveness. Am J Med 1990; 89:630-638.
115. Concato J, Shah N, Horwitz RI. Randomized controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000; 342:1887-1892.
116. Kopans DB. The 2009 US Preventative Services Task Force guidelines ignore important scientific evidence and should be revised or withdrawn. Radiology 2010; 256:15-20.
117. Zuubier R. Omissions of the US Preventive Services Task Force. Radiology 2011; 259:305.
118. Miller FG, Kallmes DF. The case of vertebroplasty trials: Promoting a culture of evidence-based procedural medicine. Spine 2010; 35:2023-2026.
119. Agency for Health Care Research and Quality. Who is involved in the effective Health Care Program>Translation, Dissemination and Implementation>National Initiative for Promoting Evidence-based Health Information. www.ahrq.gov
120. Mitra R, Do J, Alamin T, Cheng I. Facet pain in thoracic compression fractures. Pain Med 2010; 11:1674-1677.
121. Bogduk N, MacVicar J, Borowczyk J. The pain of vertebral compression fractures can arise in the posterior elements. Pain Med 2010; 11:1666-1673.
122. Brinjikji W, Comstock BA, Gray L, Kallmes DF. Local Anesthesia with Bupivavaine and Lidocaine for Vertebral Fracture Trial (LABEL): A report of outcomes and comparison with the Investigational Vertebroplasty Efficacy and Safety Trial (INVEST). AJNR Am J Neuroradiol 2010; 31:1631-1634.
123. Liu J, Li X, Tang D, Cui X, Li X, Yao M, Yu P, Qian X, Wang Y, Jiang H. Comparing pain reduction following vertebroplasty and conservative treatment for osteoporotic vertebral compression fractures: A meta-analysis of randomized controlled trials. Pain Physician 2013; In Press
124. Saxena A, Hirsch AE, Yoo AJ, Gilligan C, Hirsch JA. The use of advanced imaging and representation of Workman's Compensation in vertebral augmentation: A single-center comparison with the INVEST Trial. Pain Physician 2013; 16:NEED PAGES.
125. Fairhurst M, Fairhurst K, Berna C, Tracey I. An fMRI study exploring the overlap and differences between neural representations of physical and recalled pain. PLoS One 2012; 7:e48711.
126. Chapin H, Bagarinao E, Mackey S. Realtime fMRI applied to pain management. Neurosci Letter 2012; 520:174-178.
127. Dobrila-Dintinjana R, Nacinovi-Duleti A. Placebo in the treatment of pain. Coll Antropol 2011; 35:319-323.
128. Amanzio M, Benedetti F, Porro CA, Palermo S, Cauda F. Activation likelihood estimation meta-analysis of brain correlates of placebo analgesia in human experimental pain. Hum Brain Mapp 2013; 34:738-752.
129. Richter M, Miltner W, Weiss T. Pain words activate pain-processing neural structures. Schmerz 2011; 25:322-324.
130. Yuan W, Ming Z, Rana N, Hai L, Chenwang J, Shao-hui M. A functional magnetic resonance imaging study of human brain in pain-related areas induced by electrical stimulation with different intensities. Neurol India 2010; 58:922-927.
131. Tracey I. Imaging Pain. BJA 2008; 101:32-39.
132. Lee MC, Tracey I. Imaging Pain: a potent for investigating pain mechanisms in patients. BJA 2013; 111:64-72.
133. Brim RL, Miller FG. The potential benefit of the placebo effect in sham-controlled trials: Implications for risk-benefit assessments and informed consent. J Med Ethics 2012; 0:1-5.
134. Miller FG, Kallmes DF, Buchbinder R. Vertebroplasty and the placebo response. Radiology 2011; 259:621-625.
135. Chu WC, Wu JC, Yew DT, Zhang L, Shi L, Yeung DK, Wang D, Tong RK, Chan Y, Lao L, Leung PC, Berman, Sung JJ. Does acupuncture therapy alter activation of neural pathway for pain perception in irritable bowel syndrome?: A comparative study of true and sham acupuncture using functional magnetic resonance imaging. J Neurogastroenterol Motil 2012; 18:305-316.
136. Fritzell P. Ohlin A, Borgstrom F. Costeffectiveness of balloon kyphoplasty versus standard medical treatment in patients with osteoporotic vertebral compression fracture: A Swedish multicenter randomized controlled trial with 2-year follow-up. Spine 2011; 6:2243-2251
137. Zampini JM, White AP, McGuire KJ. Comparison of 5766 vertebral compression fractures treated with or without kyphoplasty. Clin Orthop Relat Res 2010; 468:1773-1780.
138. Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis S, Whicher D, Schwartz JS. Rethinking randomized clinical trials for Comparative Effectiveness Research: The need for transformational change. Ann Intern Med 2009; 151:206-209.
139. Farrokhi MR, Alibai E, Maghami Z. Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. J Neurosurg Spine 2011; 12:561-569.
140. Lin WC, Cheng TT, Lee YC, Wang TN, Cheng YF, Lui CC, Yu CY. New vertebral osteoporotic compression fractures after percutaneous vertebroplasty: Retrospective analysis of risk factors. J Vasc Interv Radiol 2008; 19:225-231.
141. Tseng YY, Yang TC, Tu PH, Lo YL, Yang ST. Repeated and multiple new vertebral compression fractures after percutaneous transpedicular vertebroplasty. Spine 2009; 34:1917-1922.
142. Eom KS, Kim TY. Percutaneous vertebroplasty-induced adjacent vertebral compression fracture. Pain Physician 2012; 15:E527-E532.
143. Zou J, Mei X, Zhu X, Shi Q, Yang H. The long term incidence of subsequent vertebral body fracture after vertebral augmentation therapy: A systematic review and meta-analysis. Pain Physician 2012; 15:E515-E522.
144. Lee HM, Park SY, Lee SH, Suh SW, Hong JY. Comparative analysis of clinical outcomes in patients with osteoporotic vertebral compression fractures (OVCFS): Conservative treatment versus balloon kyphoplasty. Spine J 2012; 12:998-1005.
145. Farrell MJ. Age-related changes in the structure and function of brain regions involved in pain processing. Pain Medicine 2012; 13:S37-43.
146. Chae Y, Chang DS, Lee SH, Jung WM, Lee IS, Jackson S, Kong J, Lee H, Park HJ, Lee H, Wallraven C. Inserting needles into the body: A meta-analysis of brain activity associated with acupuncture needle stimulation. J Pain 2013; 14:215-222.
147. Maeda L, Ono M, Koyama T, Oshiro Y, Sumitani M, Mashimo T, Shibata M. Human brain activity associated with painful mechanical stimulation to muscle and bone. J Anesth 2011; 25:523-530.
148. Buonocore M, Aloisis AM, Barbieri M. Gatti AM, Bonezzi C. Vertebral body innervation: Implications for pain. J Cell Physiol 2010; 222:488-491.
149. Lane JI, Maus TP, Wald JT, Thielen KR, Bobra S, Leutmer PH. Intravertebral clefts opacified during vertebroplasty: Pathogenesis, technical implications, and prognostic significance. AJNR Am J Neuroradiol 2002; 23:1642-1646.
150. Yokoyama K, Kawanishi M, Yamada M, Tanaka H, Ito Y, Hirano M, Kuroiwa T. Validity of intervertebral bone cement infusion for painful vertebral compression fractures based on the presence of vertebral mobility. AJNR AM J Neuroradiol 2013; 34:228-232.
151. Farooq N, Park JC, Pollintine P. Can Vertebroplasty restore normal loadbearing to fractured vertebre? Spine 2005; 30:1723-1730.
152. McKibbin B. The biology of fracture healing in long bones. J Bone Joint Surg 1978; 60:150-162.
153. Lau KH, Kothari V, Das A, Zhang XB, Baylink DJ. Cellular and molecular mechanisms of accelerated fracture healing by COX2 gene therapy. Studies in a mouse model of multiple fractures. Bone 2013; 53:369-381.
154. Al-Aql ZS, Alagl AS, Graves DT, Gerstenfeld LC, Einhorn TA. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 2008; 8:107-118.
155. Han S, Wan S, Li QT, Xu DT, Chen NJ, Yang F, Chen LY, Xu ZW. Is vertebroplasty a risk factor for subsequent vertebral fracture, a meta-analysis of published evidence. Pain Physician 2013; -D-13-00075R2.
156. Gilula L, Persenaire M. Subsequent fractures postvertebral augmentation: Analysis of a prospective randomized trial in osteoporotic vertebral compression fractures. AJNR Am J Neuroradiol 2013; 34:221-227.
157. Bae H, Shen M, Maurer P, Peppelman W, Beutler W, Linovitz R, Westerlund E, Peppers T, Lieberman I, Kim C, Girardi F. Clinical experience using Cortoss for treating vertebral compression fractures with vertebroplasty and kyphoplasty: Twenty fourmonth follow-up. Spine 2010; 35:E1030-1036.
158. Lieberman IH, Togawa D, Kayanja MM. Vertebroplasty and kyphoplasty: Filler materials. Spine J 2005; 5:305S-316S.
159. Chandra RV, Yoo AJ, Hirsch JA. Vertebral augmentation: Update on safety, efficacy, cost effectiveness, and increased survival? Pain Physician 2013; 16:309-320.
160. Eidt-koch D, Greiner W. Quality of life results of balloon kyphoplasty versus onsurgical management for osteoporotic vertebral fractures in Germany. Health Economics Review 2011; 1:1-7.
161. Edidin AA, Ong KL, Lau E, Kurtz SM. Life expectancy following diagnosis of a vertebral compression fracture. Osteoporo Int 2013; 24:451-458.
162. Edidin AA, Ong KL, Lau E, Kurtz SM. Mortality risk for operated and nonoperated vertebral fracture patients in the Medicare population. J Bone Miner Res 2011; 26:1617-1626.
163. Melton LJ III. Excess mortality following vertebral fracture. J Am Geriatri Soc 2000; 48:338-339.
164. Jalava T, Sarna S, Pylkkanen L, Mawer B, Kanis JA, Selby P, Davies M, Adams J, Francis RM, Robinson J, McCloskey E. Association between vertebralfracture and increased mortality in osteoporotic patients. J Bone Miner Res 2003; 18:1254-1260.
165. Hasserius R, Karlsson MK, Jonsson B, Redlund-Johnell I, Johnell O. Long-term morbidity and mortality after a clinically diagnosed vertebral fracture in the elderly: A 12and 22-year follow-up of 257 patients. Calcif Tiss Int 2005; 76:235-242.
166. Kado DM, Duong T, Stoner KL, Ensrud KE, Nevitt MC, Greendale GA, Cummings SR. Incident vertebral fractures and mortality in older women: A prospective study. Osteoporos Int 2003; 14:589-594.
167. Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: A tenyear perspective. Pain Physician 2010; 13:401-435.
168. Centers for Disease Control and Prevention (CDC). CDC Grand Rounds. Prescription drug overdoses-a US epidemic. MMWR Morb Mortal Wkly Rep 2012; 61:10-13.
169. Wang Y, Huang F, Chen L, Ke ZY, Deng ZL Clinical measurement of intravertebral pressure during vertebroplasty and kyphoplasty. Pain Physician 2013; NEED PAGES.
170. American Academy of Orthopaedic Surgeons. The treatment of symptomatic osteoporotic spinal compression fractures. Guideline and Evidence Report 2010; 19:69-85.
171. Yang LY, Wang XI, Zhou L, Fu Q. Unilateral versus bilateral kyphoplasty for osteoporotic vertebral compression fractures: A systematic review and metaanalysis of randomized controlled trials. Pain Physician 2013; In Press.
172. Lin J, Zhang L, Yang H. Unilateral versus bilateral balloon kyphoplasty for osteoporotic vertebral compression fractures. Pain Physician 2013; In Press
173. Hirsch AE, Ruchira MJ, Yoo AJ, Saxena A, Ozonoff A, Growney MJ, Hirsch JA. The use of vertebral augmentation and external beam radiation therapy in the multimodal management of malignant vertebral compression fractures. Pain Physician 2011; 14:447-458.
174. Georgy B. Feasibility, safety and cement leakage in vertebroplasty of osteoporotic and malignant compression fractures using ultra-viscous cement and hydraulic delivery system. Pain Physician 2012; 15:223-228.
175. Shah R. Sternal kyphoplasty for metastatic lung cancer: Image-guided palliative care, utilizing fluoroscopy and sonography. Pain Medicine 2012; 13:198-203.
176. Burton AW, Mendoza T, Gebhardt R, Hamid B, Nouri K, Perez-Toro M, Ting J, Koyyalagunta D;Vertebral compression fracture treatment with vertebroplasty and kyphoplasty: Experience in 497 patients with 1,156 fractures in a tertiary cancer center Pain Medicine 2011; 12:1750-1757.
177. Ortiz A, Brook AL. Sacroplasty. Tech Vasc Interv Radiol 2009; 12:52-63.
178. Wang Z, Zhen Y, Wu C, Li H, Yang Y, Shen Z, Zhao H, Yao Y. CT fluoroscopyguided percutaneous osteoplasty for the treatment of osteolytic lung cancer bone metastases to the spine and pelvis. J Vasc Interv Radiol 2012; 23:1135-1142.
179. Sun G, Wang LJ, Jin P Liu XW, Li M. Vertebroplasty for treatment of osteolytic metastases at C2 using an anterolateral approach. Pain Physician 2013; 16:E427-E434.
180. Anselmetti GC, Manca A, Tutton S, Chiara G, Kelekis A, Facchini FR, Russo F, Regge D, Montemurro F. Percutaneous vertebral augmentation assisted by peek implant in painful osteolytic vertebral metastasis involving the vertebral wall: Experience on 40 patients. Pain Physician 2013; 16: E397-E404.
181. Otten L, Bornemnn R, Jansen T, Kabir K, Pennekamp P, Wirt D, Stüwe B, Pflugmacher R. Comparison of balloon kyphoplasty with the new Kiva VCF system for the treatment of vertebral compression fractures. Pain Physician 2013; In Press.
182. Woo JH, Park HS, Han JI, Kim DY. Vertebroplasty for the compression of the dorsal root ganglion due to spinal metastasis. Pain Physican 2013; 16: E405-E410.
183. Hussain A, Erdek M. Vertebroplasty augmentation procedures: Examining the controversy. Pain Physician 2013; In Press.
184. Buchbinder R, Kallmes DF. Vertebroplasty: When randomized placebo-controlled trial results clash with common belief. Spine J 2010; 10:241-243.
185. Knavel EM, Rad AE, Thielen KR, Kallmes DF. Clinical outcomes with hemivertebral filling during percutaneous vertebroplasty. AJNR Am J Neuroradiol 2009; 30:496-499.
186. Farrar JT, Young JP Jr, La Moreaux L Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001; 94:149-158.
187. Grotle M, Brox JI, Vollestad NK. Concurrent comparison of responsiveness in pain and functional status measurements used for patients with low back pain. Spine 2004; 29:E492-501.
188. Firanescu C, Lohle PNM, deVries J, Klazen CA, Juttmann JR, Clark W, van Rooij WJ; VERTOS IV study group. A randomised sham controlled trial of vertebroplasty for painful acute osteoporotic vertebral fractures (VERTOS IV). Study Protocol. www.trialsjournal.com/content/12/1/93
189. Smith SR. Introduction to developing a protocol for observational Comparative Effectiveness Research: A user's guide. In: Velentgas P, Dreyer NA, Nourjah P, et al., editors. Developing a Protocol for Observational Comparative Effectiveness Research: A User's Guide. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jan. Available from: http://www.ncbi.nlm.nih.gov/books/NBK126177/1
190. Miller FG, Pearson SD. Linking insurance coverage for innovative invasive procedures with participation in clinical research. JAMA 2011; 306:2024-2025.
191. Pearson SD, Miller FG, Emanuel EJ. Medicare's requirement for research participation as a condition of coverage. Is it ethical? JAMA 2006; 296:988-991.
192. Johnson J, Rogers W, Jeffree R. The controversy over vertebroplasty: An analysis of the debate and proposal for a way forward. J Med Imaging Radiat Oncol 2012; 56:449-451.